Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years

被引:89
作者
Chen, Jian-Jun [1 ,2 ]
Wang, Xi-Mo [1 ,2 ]
Liu, Xing-Qiang [2 ]
Li, Wen [2 ]
Dong, Mo [2 ]
Suo, Zong-Wu [2 ]
Ding, Po [2 ]
Li, Yue [2 ]
机构
[1] Tianjin Nankai Hosp, Dept Gastroenterol, Tianjin 300100, Peoples R China
[2] Peoples Hosp Tianjin, Dept Gastroenterol, Tianjin 300121, Peoples R China
关键词
Endoscopic retrograde cholangiopancreatography; Pancreatitis; Risk factors; Systematic review; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; BILIARY SPHINCTEROTOMY; PROSPECTIVE MULTICENTER; ODDI DYSFUNCTION; COMPLICATIONS; SOMATOSTATIN; METAANALYSIS; PROPHYLAXIS; GABEXATE; STENTS;
D O I
10.1186/2047-783X-19-26
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is the most common and most severe complication associated with diagnostic and therapeutic ERCP. A multivariate analysis of risk factors for PEP is essential for identifying patients at high risk and subsequently choosing other suitable diagnoses. Methods: Pertinent publications were identified through systematic searches of MEDLINE, Elsevier, and Springer; we performed a systematic review of 12 clinical studies published in the past ten years, selected out of 451 reviewed articles, in which risk factors for pancreatitis were identified. Seven probable risk factors were evaluated, and outcomes expressed in the case of dichotomous variables, as an odds ratio (OR) (with a 95% confidence interval, 95% CI). Results: When the risk factors were analyzed, the OR for female gender was 1.40 (95% CI 1.24 to 1.58); the OR for previous PEP was 3.23 (95% CI 2.48 to 4.22); the OR for previous pancreatitis was 2.00 (95% CI 1.72 to 2.33); the OR for endoscopic sphincterotomy was 1.42 (95% CI 1.14 to 1.78); the OR for precut sphincterotomy was 2.11 (95% CI 1.72 to 2.59); the OR for Sphincter of Oddi dysfunction was 4.37 (95% CI 3.75 to 5.09); and the OR for non-prophylactic pancreatic duct stent was 2.10 (95% CI 1.63 to 2.69). Conclusions: It appears that female gender, previous PEP, previous pancreatitis, endoscopic sphincterotomy, precut sphincterotomy, Sphincter of Oddi dysfunction, and non-prophylactic pancreatic duct stent are the risk factors for post-ERCP pancreatitis.
引用
收藏
页数:7
相关论文
共 31 条
[11]   Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years [J].
Cotton, Peter B. ;
Garrow, Donald A. ;
Gallagher, Joseph ;
Romagnuolo, Joseph .
GASTROINTESTINAL ENDOSCOPY, 2009, 70 (01) :80-88
[12]   Sphincter of Oddi dysfunction: Pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone [J].
Fogel, EL ;
Eversman, D ;
Jamidar, P ;
Sherman, S ;
Lehman, GA .
ENDOSCOPY, 2002, 34 (04) :280-285
[13]   ERCP cannulation: a review of reported techniques [J].
Freeman, ML .
GASTROINTESTINAL ENDOSCOPY, 2005, 61 (01) :112-125
[14]   Complications of endoscopic biliary sphincterotomy [J].
Freeman, ML ;
Nelson, DB ;
Sherman, S ;
Haber, GB ;
Herman, ME ;
Dorsher, PJ ;
Moore, JP ;
Fennerty, MB ;
Ryan, ME ;
Shaw, MJ ;
Lande, JD ;
Pheley, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (13) :909-918
[15]   Risk factors for post-ERCP pancreatitis: a prospective, multicenter study [J].
Freeman, ML ;
DiSario, JA ;
Nelson, DB ;
Fennerty, MB ;
Lee, JG ;
Bjorkman, DJ ;
Overby, CS ;
Aas, J ;
Ryan, ME ;
Bochna, GS ;
Shaw, MJ ;
Snady, HW ;
Erickson, RV ;
Moore, JP ;
Roel, JP .
GASTROINTESTINAL ENDOSCOPY, 2001, 54 (04) :425-434
[16]   Feasibility of endoscopic retrograde cholangiopancreatography-related procedures in hemodialysis patients [J].
Hori, Yasuki ;
Naitoh, Itaru ;
Nakazawa, Takahiro ;
Hayashi, Kazuki ;
Miyabe, Katsuyuki ;
Shimizu, Shuya ;
Kondo, Hiromu ;
Yoshida, Michihiro ;
Yamashita, Hiroaki ;
Umemura, Shuichiro ;
Ban, Tessin ;
Okumura, Fumihiro ;
Sano, Hitoshi ;
Takada, Hiroki ;
Joh, Takashi .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) :648-652
[17]   Assessing the quality of reports of randomized clinical trials: Is blinding necessary? [J].
Jadad, AR ;
Moore, RA ;
Carroll, D ;
Jenkinson, C ;
Reynolds, DJM ;
Gavaghan, DJ ;
McQuay, HJ .
CONTROLLED CLINICAL TRIALS, 1996, 17 (01) :1-12
[18]  
Masci E, 2003, ENDOSCOPY, V35, P830
[19]   Risk of pancreatitis after endoscopic retrograde cholangiopancreatography and endoscopic biliary drainage [J].
Matsubayashi, Hiroyuki ;
Fukutomi, Akira ;
Kanemoto, Hideyuki ;
Maeda, Atsuyuki ;
Matsunaga, Kazuya ;
Uesaka, Katsuhiko ;
Otake, Yosuke ;
Hasuike, Noriaki ;
Yamaguchi, Yuichiro ;
Ikehara, Hisatomo ;
Takizawa, Kohei ;
Yamazaki, Kentaroh ;
Ono, Hiroyuki .
HPB, 2009, 11 (03) :222-228
[20]   Are drugs a risk factor of post-ERCP pancreatitis? [J].
Perney, P ;
Berthier, E ;
Pageaux, GP ;
Hillaire-Buys, D ;
Roques, V ;
Fabbro-Peray, P ;
Melki, M ;
Hanslik, B ;
Bauret, P ;
Larrey, D ;
Blayac, JP ;
Blanc, F .
GASTROINTESTINAL ENDOSCOPY, 2003, 58 (05) :696-700